Novo Nordisk strikes second licensing deal since frosty capital-markets day
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Novo Nordisk on Tuesday struck its second licensing deal since receiving a poor reception from investors after presenting its long-term strategy.
Original Source: MarketWatch (Dow Jones Markets & Global Business)
Comments (0)
No comments yet. Be the first to share your thoughts!
Leave a Comment